Results 121 to 130 of about 6,549 (182)

^99mTc MAA SPECT/CT pre-treatment based surrogate dosimetry and hepatotoxicity in patients following ⁹⁰Y radioembolization: association of non-tumor liver dose and clinical markers of radioembolization induced liver disease (REILD). [PDF]

Quant Imaging Med Surg
Bassir A, Dang C, Chiu K, Gampala S, Loon T, Salaskar A, Kobayashi K, Krol A, Lubin DJ.   +8 more
europepmc   +1 more source

Efficacy and safety of Y90 radioembolization combined with targeted therapy and immunotherapy in patients with unresectable hepatocellular carcinoma: a dual-center, retrospective study. [PDF]

BMC Cancer
Wang X, Jiang Q, Chen S, Li Y, Lin C, Yu W, Liu W, Qiu L, Hao M, Zeng Y, Fang Z.   +10 more
europepmc   +1 more source

Preclinical Models of Colorectal Cancer Liver Metastasis: Therapeutic Evaluation and Translational Implications. [PDF]

Oncol Res
Han YR, Lee SB.
europepmc   +1 more source

The evolution of surrogate microspheres in transarterial radioembolization: from SPECT prediction to multimodal AI-guided precision dosimetry. [PDF]

Theranostics
Gupta A, Gordon AC, Mouli SK, Lewandowski RJ, Kim DH.   +4 more
europepmc   +1 more source

Feasibility of Real-time Artificial Intelligence-based Language Translation for Bilingual Informed Consent in Interventional Radiology:An Australian Proof-of-concept. [PDF]

Interv Radiol (Higashimatsuyama)
Mitreski G, Chan P, Tamburayi Kamba C, Ng N, Duong D, Thomas R, Velaga J, Siemienowicz M, Kuan Kok H.   +8 more
europepmc   +1 more source

Meta-analysis of efficacy and safety of Yttrium-90 radioembolization (TARE) in the treatment of advanced hepatocellular carcinoma. [PDF]

Front Nucl Med
Lin H, Tan Q.
europepmc   +1 more source

Dose-Response and survival analysis after transarterial radioembolization for intrahepatic cholangiocarcinoma: A multicenter multicompartment dosimetry study. [PDF]

Eur J Nucl Med Mol Imaging
Soydal C, Ones T, Bozkurt MF, Isık EG, Selcuk NA, Coskun N, Kutlu R, Akkas BE, Onner H, Gultekin A, Ince S, Ozbay P, Karacavus S, Mesci I, Soydemir E, Salancı BV, Deniz G, Topcuoğlu OM, Ozdemir E, Otlu M, Kaya EM, Nayman A, Arslan M, Peker H, Ballı HT, Bilgili M, Celebioglu EC, Arik E, Eldem G, M D, Poyanli A, Toklu T, Ozdemir M, Kaya M, Dilek I, Celik A, Yuce G, Demir F, Kucuk NO.   +38 more
europepmc   +1 more source

Artificial intelligence across oncologic theranostics: evidence for patient stratification, dosimetry, and adaptive radiopharmaceutical therapy. [PDF]

Front Nucl Med
Banala M, Ezuddin S, Foley M, Kuker R.
europepmc   +1 more source

Use of yttrium-90 radioembolization to control liver metastases in pancreatic acinar cell carcinoma and pancreatoblastoma: Two case reports. [PDF]

World J Gastroenterol
Skorupan N, Sperling D, Nutting C, Miettinen M, Cohn A, Alewine C.   +5 more
europepmc   +1 more source

Prolonged Radiation-Induced Gastritis Following Yttrium-90 Radioembolization: A Case of Persistent Dyspepsia and Endoscopic Surveillance. [PDF]

Cureus
Latif MH, Gadallah A, Kang A, El-Halawani H, Sen S.   +4 more
europepmc   +1 more source